• Something wrong with this record ?

Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease

L. Cahlíková, R. Vrabec, F. Pidaný, R. Peřinová, N. Maafi, AA. Mamun, A. Ritomská, V. Wijaya, G. Blunden

. 2021 ; 26 (17) : . [pub] 20210829

Language English Country Switzerland

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc22003884

Grant support
GA UK 328121; SVV UK 260 548 Grantová Agentura, Univerzita Karlova
reg. No. CZ.02.1.01/0.0/0.0/18_069/0010046 Ministerstvo Školství, Mládeže a Tělovýchovy

Alzheimer's disease (AD) is a progressive age-related neurodegenerative disease recognized as the most common form of dementia among elderly people. Due to the fact that the exact pathogenesis of AD still remains to be fully elucidated, the treatment is only symptomatic and available drugs are not able to modify AD progression. Considering the increase in life expectancy worldwide, AD rates are predicted to increase enormously, and thus the search for new AD drugs is urgently needed. Due to their complex nitrogen-containing structures, alkaloids are considered to be promising candidates for use in the treatment of AD. Since the introduction of galanthamine as an antidementia drug in 2001, Amaryllidaceae alkaloids (AAs) and further isoquinoline alkaloids (IAs) have been one of the most studied groups of alkaloids. In the last few years, several compounds of new structure types have been isolated and evaluated for their biological activity connected with AD. The present review aims to comprehensively summarize recent progress on AAs and IAs since 2010 up to June 2021 as potential drugs for the treatment of AD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22003884
003      
CZ-PrNML
005      
20220127145749.0
007      
ta
008      
220113s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules26175240 $2 doi
035    __
$a (PubMed)34500673
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Cahlíková, Lucie $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
245    10
$a Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer's Disease / $c L. Cahlíková, R. Vrabec, F. Pidaný, R. Peřinová, N. Maafi, AA. Mamun, A. Ritomská, V. Wijaya, G. Blunden
520    9_
$a Alzheimer's disease (AD) is a progressive age-related neurodegenerative disease recognized as the most common form of dementia among elderly people. Due to the fact that the exact pathogenesis of AD still remains to be fully elucidated, the treatment is only symptomatic and available drugs are not able to modify AD progression. Considering the increase in life expectancy worldwide, AD rates are predicted to increase enormously, and thus the search for new AD drugs is urgently needed. Due to their complex nitrogen-containing structures, alkaloids are considered to be promising candidates for use in the treatment of AD. Since the introduction of galanthamine as an antidementia drug in 2001, Amaryllidaceae alkaloids (AAs) and further isoquinoline alkaloids (IAs) have been one of the most studied groups of alkaloids. In the last few years, several compounds of new structure types have been isolated and evaluated for their biological activity connected with AD. The present review aims to comprehensively summarize recent progress on AAs and IAs since 2010 up to June 2021 as potential drugs for the treatment of AD.
650    _2
$a Alzheimerova nemoc $x metabolismus $7 D000544
650    _2
$a Amaryllidaceae $x chemie $7 D000070378
650    _2
$a alkaloidy amarylkovitých $x metabolismus $7 D047151
650    _2
$a neurodegenerativní nemoci $x metabolismus $7 D019636
650    _2
$a prolyloligopeptidasy $x metabolismus $7 D000085822
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Vrabec, Rudolf $u Department of Pharmacognosy, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Pidaný, Filip $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Peřinová, Rozálie $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Maafi, Negar $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Mamun, Abdullah Al $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Ritomská, Aneta $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Wijaya, Viriyanata $u ADINACO Research Group, Department of Pharmaceutical Botany, Faculty of Pharmacy, Charles University, Heyrovskeho 1203, 500 05 Hradec Kralove, Czech Republic
700    1_
$a Blunden, Gerald $u School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, Hampshire P01 2DT, UK
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 26, č. 17 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34500673 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145746 $b ABA008
999    __
$a ok $b bmc $g 1751369 $s 1155033
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 26 $c 17 $e 20210829 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
GRA    __
$a GA UK 328121; SVV UK 260 548 $p Grantová Agentura, Univerzita Karlova
GRA    __
$a reg. No. CZ.02.1.01/0.0/0.0/18_069/0010046 $p Ministerstvo Školství, Mládeže a Tělovýchovy
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options